ZS has shown, Albert Whangbo says, that many factors contribute to patients dropping off their therapy—it’s not just down to patients themselves, but also to providers, pharmacies, payers, and the patient’s environment.

According to a recent study by the Get the Medications Right Institute (GTMRx), nearly a quarter of the patients surveyed said their medical team did not regularly review their medications, despite a third of the respondents saying they were currently taking four or more medications.

Despite efforts to reduce adverse drug events and improve patient safety—including the Centers for Medicare & Medicaid Services’ (CMS) in-depth undertaking to create policies, value-based purchasing programs, and other financial incentives aimed at preventing hospital ADEs—the problem perseveres. The result is an increase of about $136 billion in annual U.S. healthcare costs, much of which could be avoided.

Healthcare plans for the underserved markets, which include patients using Medicaid, Medicare Dual Advantage, or a healthcare exchange, offer limited options under the current pharmacy setup; there is also limited technology focusing on which patients are best served by which type of pharmacy.

Many studies have shown the benefits of certain medications for improving long-term outcomes in patients with chronic conditions. However, even when evidence-based recommendations are closely followed, there is a potential for adverse consequences because of the concurrent use of multiple medications.

Burnout already affected more than half of all physicians prior to the coronavirus pandemic, and it has only intensified among doctors and other healthcare workers in recent months. According to a recent survey, 65% of physicians indicated that the COVID-19 pandemic has increased their feelings of burnout, as they feel overwhelmed and helpless in the face of the virus. And increasing burnout is widely reported in nursing, pharmacy, and nearly all other clinical areas.

The good news is that a new category of solutions—precision health insight networks (PHIN)—is emerging to help overcome these barriers and advance mainstream use of precision medicine. With the right infrastructure in place, health systems and health plans can scale delivery of precision care to achieve markedly better outcomes while significantly reducing healthcare costs.

The toolkit offers a core elements checklist for assessing policies and procedures, treatment recommendations in primary care taken from the CDC, and a flow chart that maps out considerations for surgical procedures. It also provides recent information on potential threats to antimicrobial stewardship due to COVID-19.